Dentists in Arlington Heights, IL Accepting Medicare
148 Dentists found. Showing 141 - 148
 Dr. Anne Kathleen Grimes, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 3407c N Kennicott Avenue, Arlington Heights, IL 60004 Phone: 847-577-3838 |
 Dr. Dean Nichols, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 121 S Wilke Rd, #120, Arlington Heights, IL 60005 Phone: 847-392-2141 Fax: 847-392-7668 |
Dr. Madalina Ivan, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1420 N Arlington Heights Rd, Suite #130, Arlington Heights, IL 60004 Phone: 847-392-6610 |
Dr. Dennis Costis, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1792 S Arlington Heights Rd, Arlington Heights, IL 60005 Phone: 847-806-6100 |
Dr. Erika Anna Wood, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3030 W Salt Creek Ln Ste 130, Arlington Heights, IL 60005 Phone: 847-870-0475 |
Raneem Alhakim Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1307 N Rand Rd, Arlington Heights, IL 60004 Phone: 630-209-8902 |
Dr. Joseph W Lehman, D.D.S. Dentist - Endodontics Medicare: Not Enrolled in Medicare Practice Location: 605 E Algonquin Rd, Ste 400, Arlington Heights, IL 60005 Phone: 847-640-1122 Fax: 847-640-1160 |
Dr. Frank M Vitucci, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 116 West Eastman St, Suite 305, Arlington Heights, IL 60004 Phone: 847-590-5151 Fax: 847-590-0081 |
News Archive
CDH first hospital in New England to use Xenex PX-UV disinfection system
Cooley Dickinson Hospital (CDH) today announced it is the first hospital in New England to use the Xenex PX-UV disinfection system to disinfect its patient and operating rooms.
Inhaled anesthetics do not increase incidence of postoperative delirium
A study presented at ANESTHESIOLOGY 2011 in Chicago this week offered firm evidence that commonly used inhaled anesthetics such as isoflurane do not increase the incidence of postoperative delirium, which can affect how well some patients recover after surgery.
Caltech researchers discover new potential cause for Crohn's disease
The community of beneficial bacteria that live in our intestines, known as the gut microbiome, are important for the development and function of the immune system. There has been growing evidence that certain probiotics-therapies that introduce beneficial bacteria into the gut-may help alleviate some of the symptoms of intestinal disorders such as Crohn's disease.
Dynavax Technologies to present data on its SD-101 Phase 1b trial for chronic HCV infection
Dynavax Technologies Corporation announced today data from two studies that differentiate SD-101 from standard-of-care as well as emerging treatments for chronic HCV infection. The findings of a Phase 1b clinical trial and an in vitro study of SD-101's mechanism of action show that the second-generation TLR9 agonist is well tolerated and safe and induces both IFN-lambda and IFN-alpha at concentrations producing antiviral activity. The data will be presented at the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria in April 2010.
› Verified 9 days ago
Counselors
Dentists
Occupational Therapists
Psychologists
Clinical Social Workers
Pharmacists